CIK 0001756262 · Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- Phone
- 9785520900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-24 | Ranganath Anil P. See remarks | Grant or award · Stock Option (Right to Buy) | +8,479 | 8,479 | ||
| 2025-02-24 | Khayal Tamer I Chief Commercial Officer | Grant or award | +17,606 | 38,449 | ||
| 2025-02-24 | Khayal Tamer I Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +26,499 | 26,499 | ||
| 2025-01-07 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +1,083 | $13.28 | $14K | 21,926 |
| 2025-01-07 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −1,083 | $80.05 | $87K | 20,843 |
| 2025-01-07 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,083 | 15,167 | ||
| 2024-12-09 | Hernandez Gerardo Chief Financial Officer | Grant or award | +12,463 | 12,463 | ||
| 2024-12-09 | Hernandez Gerardo Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +18,922 | 18,922 | ||
| 2024-12-02 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +1,084 | $13.28 | $14K | 21,927 |
| 2024-12-02 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −1,084 | $86.40 | $94K | 20,843 |
| 2024-12-02 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,084 | 16,250 | ||
| 2024-11-11 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +1,458 | $38.46 | $56K | 22,301 |
| 2024-11-11 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −1,458 | $90.04 | $131K | 20,843 |
| 2024-11-11 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,458 | 5,834 | ||
| 2024-11-05 | Basile Edward M Director | Option exercise 10b5-1 | +6,750 | $28.12 | $190K | 7,482 |
| 2024-11-05 | Basile Edward M Director | Sale 10b5-1 | −5,296 | $83.35 | $441K | 2,186 |
| 2024-11-05 | Basile Edward M Director | Sale 10b5-1 | −1,454 | $84.30 | $123K | 732 |
| 2024-11-05 | Basile Edward M Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,750 | 0 | ||
| 2024-11-01 | Khayal Tamer I Chief Commercial Officer | Option exercise 10b5-1 | +1,083 | $13.28 | $14K | 21,926 |
| 2024-11-01 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −1,083 | $82.64 | $89K | 20,843 |
Page 5 of 20 · 390 trades